each new application brought in millions of dollars in application fees. The FDA says the fees, permitted under the 1992 Prescription Drug User Fee Act, allow it to staff up to keep drug reviews moving expeditiously through the approvals system. Critics say the half a billion dollars in fees it collects annually makes the FDA beholden to pharma.)
